Study S001171

A Phase III,Randomized,Parallel,Open-label,Multicenter Trial to Compare the Efficacy and Safety of Liraglutide and Victoza® in Patients With Type 2 Diabetes Inadequately Controlled by Oral Metformin Alone

ClinicalTrials.gov record

Registration

Registration: NCT04373967
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: NONE
Status: UNKNOWN
Enrollment: 424
Start: 2020-04-29
Primary completion: 2021-12-01
Lead sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Conditions: Type 2 Diabetes
Interventions: DRUG:Victoza®.; DRUG:Metformin Hydrochloride; DRUG:TQZ2451
Results posted: FALSE

Registered primary outcomes

glycated hemoglobin (HbA1c) [week 0,week 26]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.